Fintel reports that on December 11, 2024, Roth MKM initiated coverage of Bloom Energy (NYSE:BE) with a Neutral recommendation ...

We recently compiled a list of the 11 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Roth MKM raised the firm’s price target on Axis Capital (AXS) to $110 from $90 and keeps a Buy rating on the shares. The firm notes that while ...

Roth MKM analyst Matt Koranda raised the firm’s price target on Byrna Technologies (BYRN) to $23 from $22 and keeps a Buy rating on the shares.

Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...

Analysts at Roth Capital issued their Q1 2026 EPS estimates for shares of Uranium Energy in a research report issued to clients and investors on Monday, December 9th. Roth Capital analyst J. Reagor ...

Musk's "authentic support" for Trump, according to Roth MKM, might increase Tesla's customer base among conservative voters, ...

Brokerage Roth MKM on Monday upgraded shares of Tesla (NASDAQ: TSLA) to Buy from Neutral, arguing that Elon Musk's "authentic ...

We recently published a list of 15 AI News Investors Shouldn’t Miss. In this article, we are going to take a look at where ...

We recently compiled a list of the 15 AI News and Ratings Trending on Financial Media. In this article, we are going to take ...

Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an early-stage biopharma that seeks to solve a key bottleneck, which is ...